Literature DB >> 26671281

Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.

S Quan1, J R Sheng1, P M Abraham1, B Soliven1.   

Abstract

B7-2(-/-) non-obese diabetic (NOD) mice develop a spontaneous autoimmune polyneuropathy (SAP) that mimics the progressive form of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). In this study, we focused on the role of regulatory T cells (Tregs ) and regulatory B cells (Bregs ) in SAP. We found that deletion of B7-2 in female NOD mice led to a lower frequency and number of Tregs and Bregs in spleens and lymph nodes. Tregs but not Bregs suppressed antigen-stimulated splenocyte proliferation, whereas Bregs inhibited the T helper type 1 (Th1) cytokine response. Both Tregs and Bregs induced an increase in CD4(+) interleukin (IL)-10(+) cells, although less effectively in the absence of B7-2. Adoptive transfer studies revealed that Tregs , but not Bregs , suppressed SAP, while Bregs attenuated disease severity when given prior to symptom onset. B cell deficiency in B cell-deficient (muMT)/B7-2(-/-) NOD mice prevented the development of SAP, which would indicate that the pathogenic role of B cells predominates over its regulatory role in this model. We conclude that Bregs and Tregs control the immunopathogenesis and progression of SAP in a non-redundant fashion, and that therapies aimed at expansion of Bregs and Tregs may be an effective approach in autoimmune neuropathies.
© 2016 British Society for Immunology.

Entities:  

Keywords:  Bregs; CIDP; Guillain-Barré syndrome; Tregs; co-stimulatory molecules

Mesh:

Substances:

Year:  2016        PMID: 26671281      PMCID: PMC4778095          DOI: 10.1111/cei.12756

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  61 in total

1.  B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Juan C Patarroyo; Nicolas Molnarfi; Tara Karnezis; Klaus Lehmann-Horn; Dimitry M Danilenko; Jeffrey Eastham-Anderson; Anthony J Slavin; Christopher Linington; Claude C A Bernard; Flavius Martin; Scott S Zamvil
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

2.  From vanilla to 28 flavors: multiple varieties of T regulatory cells.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

3.  CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.

Authors:  P M Abraham; S H Quan; D Dukala; B Soliven
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

4.  Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model.

Authors:  Sylvie Amu; Sean P Saunders; Mitchell Kronenberg; Niamh E Mangan; Ann Atzberger; Padraic G Fallon
Journal:  J Allergy Clin Immunol       Date:  2010-03-20       Impact factor: 10.793

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.

Authors:  Jia-Bin Sun; Carl-Fredrik Flach; Cecil Czerkinsky; Jan Holmgren
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

Authors:  Deepak Yadav; Valeria Judkowski; Malin Flodstrom-Tullberg; Lori Sterling; William L Redmond; Linda Sherman; Nora Sarvetnick
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

8.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells.

Authors:  Magdalena Walecki; Florian Eisel; Jörg Klug; Nelli Baal; Agnieszka Paradowska-Dogan; Eva Wahle; Holger Hackstein; Andreas Meinhardt; Monika Fijak
Journal:  Mol Biol Cell       Date:  2015-06-10       Impact factor: 4.138

View more
  7 in total

Review 1.  Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Authors:  Jolien Wolbert; Mandy I Cheng; Gerd Meyer zu Horste; Maureen A Su
Journal:  JCI Insight       Date:  2020-02-13

Review 2.  The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  J Neuroinflammation       Date:  2021-03-22       Impact factor: 8.322

Review 3.  Novel pathomechanisms in inflammatory neuropathies.

Authors:  David Schafflick; Bernd C Kieseier; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  J Neuroinflammation       Date:  2017-11-28       Impact factor: 8.322

Review 4.  Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  J Clin Med       Date:  2017-01-26       Impact factor: 4.241

5.  Elimination of activating Fcγ receptors in spontaneous autoimmune peripheral polyneuropathy model protects from neuropathic disease.

Authors:  Gang Zhang; Nataliia Bogdanova; Tong Gao; Kazim A Sheikh
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

Review 6.  Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Anna Lena Fisse; Jeremias Motte; Thomas Grüter; Melissa Sgodzai; Kalliopi Pitarokoili; Ralf Gold
Journal:  Neurol Res Pract       Date:  2020-12-08

7.  Systemic IGF-1 gene delivery by rAAV9 improves spontaneous autoimmune peripheral polyneuropathy (SAPP).

Authors:  Tong Gao; Nataliia Bogdanova; Sameera Ghauri; Gang Zhang; Jianxin Lin; Kazim Sheikh
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.